Stockhead’s Prepped and Primed video series is a summary of development plans from company leaders, who share what investors can expect to see in the year ahead.

In this instalment Dr Sean Hall, CEO and executive director at Medlab (ASX:MDC), shares his outlook for 2023.

Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®.

To hear about the company’s upcoming 2023, click above.